Abstract:BACKGROUND CONTEXT The rate of multilevel fusion surgery for spinal deformity is increasing internationally. Understanding the short- and long-term outcomes and results in patient-reported health-related quality of life is important to determine the appropriateness of multilevel fusion in older adults with spinal deformity PURPOSE To determine the appropriateness and long-term outcome of multilevel fusion in older adults with spinal deformity. STUDY DESIGN/SETTING Prospective multicenter international observational study. PATIENT SAMPLE Patients ≥60 years undergoing ≥5 levels of spinal fusion from 12 international centers OUTCOME MEASURES Outcome scores recorded included the Scoliosis Research Society (SRS)22r, Oswestry Disability Index (ODI), Numeric Rating Scale (NRS) back and leg, and the EuroQol 5 dimensions (EQ-5D). Adverse events were recorded. METHODS Patients ≥60 years undergoing ≥5 levels of spinal fusion from 12 international centers were prospectively enrolled and followed at 10 weeks, 1 year, 2 years, and 5 years. Indications for surgery and surgical procedures performed were at the discretion of the treating surgeon. Patient-reported outcomes were analyzed using unadjusted mixed effects regression models. A dedicated contract research organization was hired to facilitate data collection and follow-up. RESULTS A total of 219 patients of 255 enrolled met the inclusion and exclusion criteria for this study. 80.4% of patients were female with a mean age of 67.5 (60.0-83.0) years at time of index surgery. 97 (44.3%) patients were treated in North America, 86 (39.6%) in Asia, and 36 (16.4%) in Europe. In total, 179 (81.7%%) patients completed 2-year and 118 (53.9%) completed 5-year follow-up. Comparing baseline to 2-years and 5-years, patients showed significant improvements in unadjusted least square means of SRS-22r (2.79 vs 3.70 vs 3.65), ODI (46.3% vs 26.9% vs 28.5%), NRS back (6.1 vs 2.7 vs 2.9), NRS leg (4.3 vs 2.3 vs 2.6), and EQ-5D (0.53 vs 0.74 vs 0.74). There were 307 recorded adverse events of which 40 occurred between 2 and 5 years. Twenty of the adverse events between 2 and 5 years were implant related of which 10 were revised. There were two perioperative deaths, and 3 patients died of unrelated causes prior to the 2-year follow-up. Three further deaths were recorded between 2 and 5 years. CONCLUSIONS Greater than 50% 5-year follow-up was obtained in this international prospective multicenter series of older patients, demonstrating significant benefit in multiple general and spine-specific patient-reported outcome scores at all time points following multilevel spinal fusions. This series highlights the durability of the results between 2 and 5 years with mechanical failures as the most prevalent adverse event presenting between 2 and 5 years. FDA Device/Drug Status This abstract does not discuss or include any applicable devices or drugs. The rate of multilevel fusion surgery for spinal deformity is increasing internationally. Understanding the short- and long-term outcomes and results in patient-reported health-related quality of life is important to determine the appropriateness of multilevel fusion in older adults with spinal deformity To determine the appropriateness and long-term outcome of multilevel fusion in older adults with spinal deformity. Prospective multicenter international observational study. Patients ≥60 years undergoing ≥5 levels of spinal fusion from 12 international centers Outcome scores recorded included the Scoliosis Research Society (SRS)22r, Oswestry Disability Index (ODI), Numeric Rating Scale (NRS) back and leg, and the EuroQol 5 dimensions (EQ-5D). Adverse events were recorded. Patients ≥60 years undergoing ≥5 levels of spinal fusion from 12 international centers were prospectively enrolled and followed at 10 weeks, 1 year, 2 years, and 5 years. Indications for surgery and surgical procedures performed were at the discretion of the treating surgeon. Patient-reported outcomes were analyzed using unadjusted mixed effects regression models. A dedicated contract research organization was hired to facilitate data collection and follow-up. A total of 219 patients of 255 enrolled met the inclusion and exclusion criteria for this study. 80.4% of patients were female with a mean age of 67.5 (60.0-83.0) years at time of index surgery. 97 (44.3%) patients were treated in North America, 86 (39.6%) in Asia, and 36 (16.4%) in Europe. In total, 179 (81.7%%) patients completed 2-year and 118 (53.9%) completed 5-year follow-up. Comparing baseline to 2-years and 5-years, patients showed significant improvements in unadjusted least square means of SRS-22r (2.79 vs 3.70 vs 3.65), ODI (46.3% vs 26.9% vs 28.5%), NRS back (6.1 vs 2.7 vs 2.9), NRS leg (4.3 vs 2.3 vs 2.6), and EQ-5D (0.53 vs 0.74 vs 0.74). There were 307 recorded adverse events of which 40 occurred between 2 and 5 years. Twenty of the adverse events between 2 and 5 years were implant related of which 10 were revised. There were two perioperative deaths, and 3 patients died of unrelated causes prior to the 2-year follow-up. Three further deaths were recorded between 2 and 5 years. Greater than 50% 5-year follow-up was obtained in this international prospective multicenter series of older patients, demonstrating significant benefit in multiple general and spine-specific patient-reported outcome scores at all time points following multilevel spinal fusions. This series highlights the durability of the results between 2 and 5 years with mechanical failures as the most prevalent adverse event presenting between 2 and 5 years.

Long-term Outcomes After Adult Spinal Deformity Surgery Using Lateral Interbody Fusion

Treatment of Degenerative Lumbar Scoliosis with Selective Segmental Transforaminal Lumbar Interbody Fusion and Posterior Spinal Fusion

Lateral lumbar interbody fusion for severe lumbar spinal stenosis: a randomized controlled trial with 1-year follow-up

Does Lateral Lumbar Interbody Fusion Decrease the Grading of Lenke-Silva Classification and Determine the Optimal Fusion Level in Severe Adult Degenerative Scoliosis?

[Long-Term Clinical Outcomes of Selective Segmental Transforaminal Lumbar Interbody Fusion and Posterior Spinal Fusion for Degenerative Lumbar Scoliosis].

Long-term clinical outcomes of selective segmental transforaminal lumbar interbody fusion combined with posterior spinal fusion for degenerative lumbar scoliosis.

Comparison of Functional Outcome and Quality of Life in Patients With Idiopathic Scoliosis Treated by Spinal Fusion.

Perioperative Predictive Factors for Positive Outcomes in Spine Fusion for Adult Deformity Correction

Lateral interbody release for fused vertebrae via transpsoas approach in adult spinal deformity surgery: a preliminary report of radiographic and clinical outcomes

Spinal deformity in elderly patients: comparison of two distal termination sites of lumbar curve fusion

Radiographic and Clinical Outcomes following Combined Oblique Lumbar Interbody Fusion and Lateral Instrumentation for the Treatment of Degenerative Spine Deformity: A Preliminary Retrospective Study

Deformity Correction with Interbody Fusion Using Lateral versus Posterior Approach in Adult Degenerative Scoliosis: A Systematic Review and Observational Meta-analysis

Long Segment Fusion for Adult Degenerative Scoliosis: Long-Term Outcomes and Sagittal Complications

Stand-alone minimally invasive lateral lumbar interbody fusion: multicenter clinical outcomes

Comparison of long fusion terminating at L5 versus the sacrum in treating adult spinal deformity: a meta-analysis

Fusion technique does not affect short-term patient-reported outcomes for lumbar degenerative disease

[Short Fusion and Long Fusion for Degenerative Lumbar Scoliosis with Lumbar Stenosis].

The Radiologic and Clinical Outcomes of Oblique Lateral Interbody Fusion for Correction of Adult Degenerative Lumbar Deformity

Short-term clinical outcomes and safety evaluation of extreme lateral interbody fusion for the treatment of lumbar degenerative diseases

The Radiological Outcomes of One-Stage Posterior-Only Hemivertebra Resection and Short Segmental Fusion for Lumbosacral Hemivertebra: a Minimum of 5 Years of Follow-Up

154. Five-year outcomes of prospective evaluation of elderly deformity surgery: a multicenter international study on patients over 60 years of age